Mutagenesis and structural analysis reveal the CTX-M β-lactamase active site is optimized for cephalosporin catalysis and drug resistance
Journal of Biological Chemistry · 2023
DOI: 10.1016/j.jbc.2023.104630 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Shuo Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: beta-Lactamases, Catalytic Domain, Cephalosporins, Drug Resistance. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, US Department of Energy.
Abstract (Originalsprache)
CTX-M β-lactamases are a widespread source of resistance to β-lactam antibiotics in Gram-negative bacteria. These enzymes readily hydrolyze penicillins and cephalosporins, including oxyimino-cephalosporins such as cefotaxime. To investigate the preference of CTX-M enzymes for cephalosporins, we examined eleven active-site residues in the CTX-M-14 β-lactamase model system by alanine mutagenesis to assess the contribution of the residues to catalysis and specificity for the hydrolysis of the penicillin, ampicillin, and the cephalosporins cephalothin and cefotaxime. Key active site residues for class A β-lactamases, including Lys73, Ser130, Asn132, Lys234, Thr216, and Thr235, contribute significantly to substrate binding and catalysis of penicillin and cephalosporin substrates in that alanine substitutions decrease both kcat and kcat/KM. A second group of residues, including Asn104, Tyr105, Asn106, Thr215, and Thr216, contribute only to substrate binding, with the substitutions decreasing only kcat/KM. Importantly, calculating the average effect of a substitution across the 11 active-site residues shows that the most significant impact is on cefotaxime hydrolysis while ampicillin hydrolysis is least affected, suggesting the active site is highly optimized for cefotaxime catalysis. Furthermore, we determined X-ray crystal structures for the apo-enzymes of the mutants N106A, S130A, N132A, N170A, T215A, and T235A. Surprisingly, in the structures of some mutants, particularly N106A and T235A, the changes in structure propagate from the site of substitution to other regions of the active site, suggesting that the impact of substitutions is due to more widespread changes in structure and illustrating the interconnected nature of the active site.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, Texas, USA.
- Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas, USA.
- Department of Molecular Biophysics and Integrated Bioimaging, Berkeley Center for Structural Biology, Lawrence Berkeley National Laboratory, Berkeley, California, USA.
- Department of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, Texas, USA; Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas, USA. Electronic address: ti…
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- US Department of Energy
- National Institute of General Medical Sciences
- National Institute of Allergy and Infectious Diseases
- Welch Foundation
- Office of Science
- National Institutes of Health
Zitieren
APA
Lu, S., Montoya, M., Hu, L., Neetu, N., Sankaran, B., Prasad, B. V. V., & Palzkill, T. (2023). Mutagenesis and structural analysis reveal the CTX-M β-lactamase active site is optimized for cephalosporin catalysis and drug resistance. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.104630
Vancouver
Lu S, Montoya M, Hu L, Neetu N, Sankaran B, Prasad BVV, et al. Mutagenesis and structural analysis reveal the CTX-M β-lactamase active site is optimized for cephalosporin catalysis and drug resistance. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.104630
BibTeX
@article{Lu2023,
author = {Lu, Shuo and Montoya, Miranda and Hu, Liya and Neetu, Neetu and Sankaran, Banumathi and Prasad, B V Venkataram and Palzkill, Timothy},
title = {Mutagenesis and structural analysis reveal the CTX-M β-lactamase active site is optimized for cephalosporin catalysis and drug resistance},
journal = {Journal of Biological Chemistry},
year = {2023},
doi = {10.1016/j.jbc.2023.104630}
}
EUVIMED